Clinical Trials Logo

Endocrine Gland Neoplasms clinical trials

View clinical trials related to Endocrine Gland Neoplasms.

Filter by:
  • Not yet recruiting  
  • Page 1

NCT ID: NCT06416085 Not yet recruiting - Advanced Cancer Clinical Trials

Psilocybin-assisted Existential, Attachment and RelationaL (PEARL) Therapy for Patients With Advanced Cancer

Start date: June 1, 2024
Phase: Phase 2
Study type: Interventional

The PEARL Pilot is a phase II open-label trial. Participants will receive a single high-dose (25 mg) of psilocybin in the context of Psilocybin-assisted Existential, Attachment and RelationaL (PEARL) therapy.

NCT ID: NCT04198402 Not yet recruiting - Fecal Microbiota Clinical Trials

Microbiotic Analysis in Digestive Endocrine Tumors

MicroTEND
Start date: January 2020
Phase:
Study type: Observational

Incidence of digestive neuroendocrine tumors are increasing. Analysis of individual microbiota is a way to explore new neoplastic mechanisms, tumor identification and therapeutic orientations. This prospective pilot study aims to describe fecal bacterial phylogeny of patients with digestive neuroendocrine tumor. Bacterial genomic signature will be recorded at initiation of Lanreotide treatment in naive patient with digestive neuroendocrine tumor (pancreas or small intestine), metastatic or locally advanced, as well as after one year follow up.